>
pdufa.bio

EVO756

Updated ยทnext FDA decision on the calendar

EVO756 is a Evommune, Inc. program. Its next catalyst is a Readout in Q3 2026. Every date links its source.

EVMN catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Evommune, Inc. (EVMN). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Q3 2026EVMN

Questions

When is EVO756's next FDA decision or readout?

The next tracked catalyst for EVO756 is a Readout in Q3 2026.

What happened at EVO756's most recent FDA decision?

No FDA decision for EVO756 is in our archive yet.

Who makes EVO756?

Evommune, Inc. (EVMN).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.